BioHarvest Sciences Pre-Tax Income 2020-2024 | BHST
BioHarvest Sciences pre-tax income from 2020 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
BioHarvest Sciences Annual Pre-Tax Income (Millions of US $) |
2023 |
$-13 |
2022 |
$-11 |
2021 |
$-10 |
2020 |
$-7 |
2019 |
$-5 |
2019 |
$-5 |
2018 |
$-5 |
BioHarvest Sciences Quarterly Pre-Tax Income (Millions of US $) |
2024-06-30 |
$-1 |
2024-03-31 |
$-7 |
2023-12-31 |
$-7 |
2023-09-30 |
$-2 |
2023-06-30 |
$-3 |
2023-03-31 |
$-1 |
2022-12-31 |
$-3 |
2022-09-30 |
$-4 |
2022-06-30 |
$-2 |
2022-03-31 |
$-2 |
2021-12-31 |
$-2 |
2021-09-30 |
$-3 |
2021-06-30 |
$2 |
2021-03-31 |
$-7 |
2020-12-31 |
$-3 |
2020-09-30 |
$-2 |
2020-06-30 |
$-1 |
2020-03-31 |
$-0 |
2019-12-31 |
|
2019-09-30 |
$-1 |
2019-06-30 |
$-1 |
2019-03-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-BIOMED/GENE |
$0.098B |
$0.013B |
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
|